[HTML][HTML] Cell cycle regulation and anticancer drug discovery

J Bai, Y Li, G Zhang - Cancer biology & medicine, 2017 - ncbi.nlm.nih.gov
Cellular growth, development, and differentiation are tightly controlled by a conserved
biological mechanism: the cell cycle. This cycle is primarily regulated by cyclin-dependent …

[PDF][PDF] Targeting cell-cycle machinery in cancer

JM Suski, M Braun, V Strmiska, P Sicinski - Cancer cell, 2021 - cell.com
Abnormal activity of the core cell-cycle machinery is seen in essentially all tumor types and
represents a driving force of tumorigenesis. Recent studies revealed that cell-cycle proteins …

Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors

I Collins, MD Garrett - Current opinion in pharmacology, 2005 - Elsevier
The cyclin-dependent kinase (CDK) family of serine/threonine kinases regulate progression
through each stage of the cell division cycle and as such are major targets for deregulation …

The history and future of targeting cyclin-dependent kinases in cancer therapy

U Asghar, AK Witkiewicz, NC Turner… - Nature reviews Drug …, 2015 - nature.com
Cancer represents a pathological manifestation of uncontrolled cell division; therefore, it has
long been anticipated that our understanding of the basic principles of cell cycle control …

Cyclin-dependent kinase inhibitors as potential targeted anticancer agents

I Diaz-Padilla, LL Siu, I Duran - Investigational new drugs, 2009 - Springer
Cyclin-dependent kinases (CDKs) are core components of the cell cycle machinery that
govern the transition between phases during cell cycle progression. Genes involved in cell …

[HTML][HTML] CDK4: a master regulator of the cell cycle and its role in cancer

SJ Baker, PI Poulikakos, HY Irie, S Parekh… - Genes & …, 2022 - ncbi.nlm.nih.gov
The cell cycle is regulated in part by cyclins and their associated serine/threonine cyclin-
dependent kinases, or CDKs. CDK4, in conjunction with the D-type cyclins, mediates …

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs

C Sánchez-Martínez, LM Gelbert, MJ Lallena… - Bioorganic & medicinal …, 2015 - Elsevier
Sustained proliferative capacity is a hallmark of cancer. In mammalian cells proliferation is
controlled by the cell cycle, where cyclin-dependent kinases (CDKs) regulate critical …

[PDF][PDF] Cyclin-dependent kinase pathways as targets for cancer treatment

GI Shapiro - J Clin Oncol, 2006 - academia.edu
Cyclin-dependent kinases (cdks) are critical regulators of cell cycle progression and RNA
transcription. A variety of genetic and epigenetic events cause universal overactivity of the …

Complexities in the development of cyclin-dependent kinase inhibitor drugs

EA Sausville - Trends in molecular medicine, 2002 - cell.com
Abnormalities in the normal regulation of the cell cycle are a hallmark of neoplasia. Drugs
directed against the cyclin-dependent kinases (CDKs), which govern the normal orderly …

CDK4 and CDK6 kinases: From basic science to cancer therapy

A Fassl, Y Geng, P Sicinski - Science, 2022 - science.org
BACKGROUND Cyclins and cyclin-dependent kinases (CDKs) drive cell division. Of
particular importance to the cancer field are D-cyclins, which activate CDK4 and CDK6. In …